Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|September 13, 2013
Development of peptide and protein based radiopharmaceuticalsEvelien Wynendaele, Nathalie Bracke, Sofie Stalmans, et al.Analytical Chemistry|December 25, 2019
LC-MS Compatible Antiadsorption Diluent for Peptide AnalysisFrederick Verbeke, Nathalie Bracke, Nathan Debunne, et al.Journal of Pharmaceutical and Biomedical Analysis|September 18, 2015
An analytical quality by design (aQbD) approach for a L-asparaginase activity methodHan Yao, Jochem Vancoillie, Matthias D'Hondt, et al.Journal of Pharmaceutical and Biomedical Analysis|December 21, 2016
Hydrophilic interaction liquid chromatography method development and validation for the assay of HEPES zwitterionic bufferXiaolong Xu, Bert Gevaert, Nathalie Bracke, et al.Manual Therapy|November 7, 2012
Patients' priorities regarding outpatient physiotherapy care: a qualitative and quantitative studyWim Peersman, Toni Rooms, Nathalie Bracke, et al.Journal of Pharmaceutical and Biomedical Analysis|July 22, 2014
Related impurities in peptide medicinesMatthias D'Hondt, Nathalie Bracke, Lien Taevernier, et al.Biomed Research International|August 6, 2016
Quantitative In Vitro and In Vivo Evaluation of Intestinal and Blood-Brain Barrier Transport Kinetics of the Plant N-Alkylamide PellitorineLieselotte Veryser, Nathalie Bracke, Evelien Wynendaele, et al.Ageing Research Reviews|February 23, 2016
Regulatory development of geriatric medicines: To GIP or not to GIP?Bart De Spiegeleer, Evelien Wynendaele, Nathalie Bracke, et al.Toxicology Letters|June 29, 2016
Blood-brain barrier transport kinetics of the cyclic depsipeptide mycotoxins beauvericin and enniatinsLien Taevernier, Nathalie Bracke, Lieselotte Veryser, et al.Protein and Peptide Letters|February 16, 2016
Exploration of the Medicinal Peptide SpaceBert Gevaert, Sofie Stalmans, Evelien Wynendaele, et al.Pageof 3